載入...
Development of the CK‐MB‐1 trastuzumab‐resistant HER2‐positive breast cancer cell line and xenograft animal models
BACKGROUND: Patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who fail to respond to anti‐HER2 treatments have poor prognoses. Most trastuzumab‐resistant breast cancer cell lines available from biobanks feature either phosphoinositide‐3‐kinase, catalytic, alpha (PI...
Na minha lista:
| 發表在: | Cancer Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7982635/ https://ncbi.nlm.nih.gov/pubmed/33665980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3824 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|